Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $806,659 - $987,417
-8,944 Reduced 66.74%
4,457 $490,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $80,627 - $96,739
844 Added 6.72%
13,401 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $865,196 - $964,009
-8,585 Reduced 40.61%
12,557 $1.37 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $2.05 Million - $2.41 Million
21,142 New
21,142 $2.14 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $58,539 - $67,778
605 Added 10.67%
6,274 $607,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $578,634 - $699,384
5,669 New
5,669 $616,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $345,522 - $384,647
-4,401 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $156,641 - $169,848
-1,914 Reduced 30.31%
4,401 $367,000
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $221,700 - $258,570
3,042 Added 92.94%
6,315 $531,000
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $216,738 - $262,036
3,273 New
3,273 $262,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $1.1 Million - $1.33 Million
-18,108 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $1.04 Million - $1.15 Million
18,108 New
18,108 $1.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.